Read Trending Stories
- » Consumer Biz Recap: Talbots Shares CRASH HARD, Time Warner Eyes Sports Website
- » Global Investors Opt for Safety as Spain Remains Scary
- » Do Spain's Red Flags Scream Caution?
- » Consumer Biz Recap: Toyota Needs New Markets, Wal-Mart's Express Update
- » Yahoo: You'll Forget Chrome and Safari When You See This
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Delcath Systems (DCTH)
- Mentor Graphics Corp (MENT)
- Complete Genomics (GNOM)
The S&P 500 (NYSEARCA:SPY) is up by 1.22% today and stands at 1,341. Bulls are taking control, and these 3 stocks are especially benefitting.
Genworth Financial, Inc. (NYSE:GNW) 4Q report was very positive. Mortgage insurance losses are down about 70%, and EPS beat the consensus. GNW shares recently traded at $8.98, up $0.94, or 11.69%. They have traded in a 52-week range of $4.80 to $14.44. Volume today was 22,474,997 shares versus a 3-month average volume of 9,258,950 shares. The company’s trailing earnings are $-0.29 per share.
Earnings Report: Visa Inc. First Quarter Earnings Sneak Peek.
Tenet Healthcare Corporation (NYSE:THC) climbed for the first few hours of trading today. The company just inked deals with Blue Cross and Blue Shield of Illinois and Anthem of Missouri. THC shares recently traded at $5.86, up $0.43, or 7.92%. They have traded in a 52-week range of $3.46 to $7.70. Volume today was 14,685,120 shares versus a 3-month average volume of 7,597,840 shares. The company’s trailing P/E is 14.14, while trailing earnings are $0.42 per share.
Gilead Sciences, Inc. (NASDAQ:GILD): New data and research from Gilead points to a two-drug combination that could cure patients with Hepatitis C. The stock is up as a result even if earnings and guidance are weak otherwise. GILD shares recently traded at $54.30, up $4.99, or 10.12%. They have traded in a 52-week range of $34.45 to $49.63. Volume today was 26,725,192 shares versus a 3-month average volume of 9,455,160 shares. The company’s trailing P/E is 15.83, while trailing earnings are $3.42 per share.
Don’t Miss: Neurocrine Biosciences Inc. Fourth Quarter Earnings Sneak Peek.
To contact the reporter on this story: Scott Gillette at staff.writers@wallstcheatsheet.com
To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!


